It is assumed that the accumulation of amyloid beta and tau imaging as criteria for further testing would provide more definitive results, which may indicate that the differential diagnosis between AD and MCI is not easy, and further investigation is recommended. This evidence concerns the gene MAPT and Alzheimer disease.